Physician profile

Stuart Pettijohn

Dentist · Grand Rapids, MI

NPI 1710207097

$518.24

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$172.84
Education$75.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Dentsply Sirona INC $325.85 2019-2024 Cerec
Straumann USA LLC $75.00 2023
Zimmer Biomet Holdings, INC. $51.55 2019
Coltene Whaledent INC. $16.28 2023
Philips North America LLC $14.67 2023
Elevate Oral Care $13.32 2024 Advantage Arrest, Fluorimax 5000, Just Right 5000
Dental Health Products, INC. $11.84 2019
Voco America INC. $9.73 2023 Futurabond U, Grandio Seal, Rebilda Dc

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Stuart Pettijohn

$518.24

in general payments reported 2019-2025

Years
2019-2024
Top company
Dentsply Sirona INC

https://glasscript.com/doctor/1237656/stuart-pettijohn

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.